Related Experiment Videos
Dermatomyositis complicating penicillamine treatment
Annals of the Rheumatic Diseases
|February 1, 1977
Summary
Dermatomyositis developed in a rheumatoid arthritis patient during D-penicillamine treatment. Symptoms resolved completely after discontinuing the drug, suggesting a causal link.
Area of Science:
- Rheumatology
- Dermatology
- Clinical Pharmacology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- D-penicillamine is a disease-modifying antirheumatic drug (DMARD) used in RA treatment.
- Drug-induced conditions can complicate RA management.
Observation:
- A patient with rheumatoid arthritis developed dermatomyositis.
- The dermatomyositis emerged during treatment with D-penicillamine.
- Dermatomyositis is an idiopathic inflammatory condition affecting muscles and skin.
Findings:
- The patient's dermatomyositis showed complete remission upon D-penicillamine withdrawal.
- This temporal association suggests D-penicillamine as a potential cause of dermatomyositis in this case.
- Differential diagnoses for the observed symptoms were considered.
Implications:
- Clinicians should consider drug-induced dermatomyositis in RA patients on D-penicillamine presenting with suggestive symptoms.
- Discontinuation of D-penicillamine may be a crucial step in managing such cases.
- Further investigation into the mechanisms of drug-induced dermatomyositis is warranted.